Guardian Wealth Management (Illinois)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-541
Closed -$33.1K – 79
2025
Q1
$33.1K Buy
541
+3
+0.6% +$175 0.02% 120
2024
Q4
$30.4K Buy
538
+5
+0.9% +$279 0.02% 133
2024
Q3
$27.6K Buy
533
+5
+0.9% +$235 0.02% 133
2024
Q2
$21.9K Buy
528
+6
+1% +$268 0.02% 135
2024
Q1
$28.3K Buy
522
+5
+1% +$255 0.02% 128
2023
Q4
$26.5K Buy
517
+114
+28% +$5.98K 0.02% 132
2023
Q3
$23.4K Sell
403
-125
-24% -$7.66K 0.02% 131
2023
Q2
$33.8K Buy
528
+4
+0.8% +$268 0.03% 119
2023
Q1
$36.3K Buy
524
+8
+2% +$564 0.04% 119
2022
Q4
$37.1K Buy
516
+1
+0.2% +$75 0.04% 127
2022
Q3
$37K Buy
515
+3
+0.6% +$218 0.04% 119
2022
Q2
$39K Buy
512
+4
+0.8% +$305 0.04% 119
2022
Q1
$37K Sell
508
-11
-2% -$739 0.04% 132
2021
Q4
$32K Buy
+519
New +$30.4K 0.03% 131

Other funds holding BMY

Guardian Wealth Management (Illinois)'s BMY Position: Q2 2025 in Review

Guardian Wealth Management (Illinois) sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 541 shares — an estimated $33.1K sold.

Guardian Wealth Management (Illinois) first reported a position in BMY in Q4 2021 and held it in 14 quarters. The position peaked at $39K in Q2 2022. 2,299 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Guardian Wealth Management (Illinois) reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Guardian Wealth Management (Illinois) sold 541 Bristol-Myers Squibb shares in Q2 2025, an estimated $33.1K.
  • Guardian Wealth Management (Illinois) first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 14 quarters.
  • Guardian Wealth Management (Illinois)'s Bristol-Myers Squibb position peaked at $39K in Q2 2022.
  • 2,299 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2025, filed 14 Aug 2025.